Cystic fibrosis
Once-daily cystic fibrosis treatment now available on the NHS
Redefining the cystic fibrosis clinical landscape with Dr Uta Hill
Understanding Aspergillus: a driver of COPD exacerbations and mortality
Update lung transplantation guidelines due to unfounded gender differences, say researchers
In conversation with consultant paediatric chest physician Professor Andy Bush
Focus on diagnostic imaging for respiratory conditions: panel discussion
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
MHRA issues advice as Burkholderia cenocepacia outbreak linked to carbomer eye gels
MHRA extends license of two cystic fibrosis drugs for children aged two to five
Kaftrio approval for cystic fibrosis extended by EMA from six years of age